AQUINOX PHARMACEUTICALS, INC (35) | Human Resources (12)

Browse by Subcategory

Recent Contracts

Employment Agreement, dated April 14, 2021, by and between Neoleukin Therapeutics, Inc. and Priti Patel (Filed With SEC on March 1, 2022)
Neoleukin Therapeutics, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on May 14, 2021)
Separation Agreement and Release, dated August 5, 2019, by and between Aquinox Pharmaceuticals, Inc., and David J. Main (Filed With SEC on August 6, 2019)
Transition Retention Agreement, dated August 5, 2019, by and between Aquinox Pharmaceuticals, Inc., and Kamram Alam (Filed With SEC on August 6, 2019)
Executive Employment Agreement, dated September 29, 2020, by and between Neoleukin Therapeutics, Inc., and Holly Vance (Filed With SEC on March 25, 2021)
Forms of Restricted Stock Unit Agreement and Restricted Stock Unit Grant Notice for Registrants 2014 Equity Incentive Plan (Filed With SEC on August 12, 2020)
Employment Agreement, dated March 16, 2020, by and between Neoleukin Therapeutics, Inc. and Robert Ho (Filed With SEC on May 6, 2020)
Amended and Restated Executive Employment Agreement, dated April 15, 2020, by and between Neoleukin Therapeutics, Inc., and Jonathan G. Drachman (Filed With SEC on April 17, 2020)
Neoleukin Therapeutics, Inc. 2014 Equity Incentive Plan, as amended November 12, 2019 (Filed With SEC on November 14, 2019)
Employment Agreement, dated August 5, 2019, by and between Aquinox Pharmaceuticals, Inc., and Jonathan G. Drachman (Filed With SEC on August 6, 2019)
Executive Employment Agreement Amendment for David Main (Filed With SEC on August 1, 2019)
Executive Employment Agreement Amendment for Kamran Alam (Filed With SEC on August 1, 2019)